Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas

  1. Melero, I.
  2. Duarte, M.
  3. Ruiz, J.
  4. Sangro, B.
  5. Galofré, J.C.
  6. Mazzolini, G.
  7. Bustos, M.
  8. Qian, C.
  9. Prieto, J.
Journal:
Gene Therapy

ISSN: 0969-7128

Year of publication: 1999

Volume: 6

Issue: 10

Pages: 1779-1784

Type: Article

DOI: 10.1038/SJ.GT.3301010 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals